Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis c Genotype 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00160251
What this trial is testing

Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 357
Large-scale testing (Phase 3)Study completedNCT03487107
What this trial is testing

Phase 3 Study of Yimitasvir Phosphate Capsules

Who this might be right for
Chronic HCV Infection
Sunshine Lake Pharma Co., Ltd. 362
Testing effectiveness (Phase 2)Study completedNCT00546715
What this trial is testing

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)Study completedNCT00292084
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Testing effectiveness (Phase 2)Study completedNCT00115908
What this trial is testing

Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Human Genome Sciences Inc. 458
Early research (Phase 1)Ended earlyNCT01651767
What this trial is testing

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 11
Testing effectiveness (Phase 2)Study completedNCT00561353
What this trial is testing

TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec Pharmaceuticals, Ireland 121
Large-scale testing (Phase 3)WithdrawnNCT01608737
What this trial is testing

A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT00781274
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 32
Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Large-scale testing (Phase 3)Study completedNCT00780910
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 109
Large-scale testing (Phase 3)Study completedNCT01433887
What this trial is testing

Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 535
Large-scale testing (Phase 3)Study completedNCT02442284
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis CCirrhosisHepatitis C Virus
AbbVie 99
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Not applicableStudy completedNCT02669940
What this trial is testing

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis CGenotype 1
AbbVie 158
Large-scale testing (Phase 3)Study completedNCT01728324
What this trial is testing

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 496
Large-scale testing (Phase 3)Study completedNCT01716585
What this trial is testing

Evaluate Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 636
Next Page